Synergistic Suppression of Early Phase of Adipogenesis by Microsomal PGE Synthase-1 (PTGES1)-Produced PGE2 and Aldo-Keto Reductase 1B3-Produced PGF2α

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Fujimori, Ko ^a   Yano, Mutsumi ^a   Ueno, Toshiyuki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTACTASE 1B3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; L 161982; OXIDOREDUCTASE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 1; PROSTAGLANDIN SYNTHASE 2; PROSTAGLANDIN SYNTHASE 3; SMALL INTERFERING RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; CYTOSOL; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; INTRACELLULAR SPACE; MICROSOME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROADIPOCYTE; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN BINDING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; DINOPROST; DINOPROSTONE; DNA PRIMERS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICROSOMES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84866142076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044698     Document Type: Article

References (37)

1. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, et al. (2008) The metabolic syndrome. Endocr Rev 29: 777-822.
2. Attie AD, Scherer PE, (2009) Adipocyte metabolism and obesity. J Lipid Res 50 (Suppl):: S395-S399.
3. Kershaw EE, Flier JS, (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556.
4. Spiegelman BM, Flier JS, (2001) Obesity and the regulation of energy balance. Cell 104: 531-543.
5. Cristancho AG, Lazar MA, (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722-734.
6. Lefterova MI, Lazar MA, (2009) New developments in adipogenesis. Trends Endocrinol Metab 20: 107-114.
7. Christodoulides C, Vidal-Puig A, (2010) PPARs and adipocyte function. Mol Cell Endocrinol 318: 61-68.
8. Siersbaek R, Nielsen R, Mandrup S, (2010) PPARγ in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett 584: 3242-3249.
9. Tontonoz P, Spiegelman BM, (2008) Fat and beyond: the diverse biology of PPARγ. Annu Rev Biochem 77: 289-312.
10. Sharma AM, Staels B, (2007) Review: Peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92: 386-395.
11. Fujimori K, Aritake K, Urade Y, (2007) A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J Biol Chem 282: 18458-18466.
12. Fujimori K, Maruyama T, Kamauchi S, Urade Y, (2012) Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated Δ12-PGJ2 acting through PPARγ-dependent and independent pathways. Gene 505: 46-52.
13. Fujitani Y, Aritake K, Kanaoka Y, Goto T, Takahashi N, et al. (2010) Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. FEBS J 277: 1410-1419.
14. Vassaux G, Gaillard D, Ailhaud G, Negrel R, (1992) Prostacyclin is a specific effector of adipose cell differentiation. Its dual role as a cAMP- and Ca2+-elevating agent. J Biol Chem 267: 11092-11097.
15. Vassaux G, Gaillard D, Darimont C, Ailhaud G, Negrel R, (1992) Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology 131: 2393-2398.
16. Fujimori K, Ueno T, Amano F, (2010) Prostaglandin F2α suppresses early phase of adipogenesis, but is not associated with osteoblastogenesis in mouse mesenchymal stem cells. Prostaglandins Other Lipid Mediat 93: 52-59.
17. Fujimori K, Ueno T, Nagata N, Kashiwagi K, Aritake K, et al. (2010) Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2α synthase. J Biol Chem 285: 8880-8886.
18. Ueno T, Fujimori K, (2011) Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascade. FEBS J 278: 2901-2912.
19. Tsuboi H, Sugimoto Y, Kainoh T, Ichikawa A, (2004) Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 322: 1066-1072.
20. Inazumi T, Shirata N, Morimoto K, Takano H, Segi-Nishida E, et al. (2011) Prostaglandin E-EP4 signaling suppresses adipocyte differentiation in mouse embryonic fibroblasts via an autocrine mechanism. J Lipid Res 52: 1500-1508.
21. Hara S, Kamei D, Sasaki Y, Tanemoto A, Nakatani Y, et al. (2010) Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models. Biochimie 92: 651-659.
22. Legler DF, Bruckner M, Uetz-von Allmen E, Krause P, (2010) Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 42: 198-201.
23. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B, (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 96: 7220-7225.
24. Samuelsson B, Morgenstern R, Jakobsson PJ, (2007) Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 59: 207-224.
25. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, et al. (2002) Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291: 884-889.
26. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I, (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275: 32775-32782.
27. Sugimoto Y, Narumiya S, (2007) Prostaglandin E receptors. J Biol Chem 282: 11613-11617.
28. Fletcher BS, Kujubu DA, Perrin DM, Herschman HR, (1992) Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 267: 4338-4344.
29. Kudo I, Murakami M, (2005) Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 38: 633-638.
30. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B, (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 96: 7220-7225.
31. Hetu PO, Riendeau D, (2007) Down-regulation of microsomal prostaglandin E2 synthase-1 in adipose tissue by high-fat feeding. Obesity 15: 60-68.
32. Xie Y, Kang X, Ackerman WEt, Belury MA, Koster C, et al. (2006) Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab 8: 83-93.
33. Murakami M, Nakatani Y, Tanioka T, Kudo I, (2002) Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 68-69: 383-399.
34. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M, (2005) Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 338: 70-76.
35. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, et al. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792.
36. Jabbour HN, Sales KJ, Boddy SC, Anderson RA, Williams AR, (2005) A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2α synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway. Endocrinology 146: 4657-4664.
37. Sales KJ, Grant V, Jabbour HN, (2008) Prostaglandin E2 and F2α activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol 285: 51-61.